Unknown

Dataset Information

0

Artificial Membrane Fusion Triggered by Strain-Promoted Alkyne-Azide Cycloaddition.


ABSTRACT: Artificial systems for controlled membrane fusion applicable for drug delivery would ideally use triggers that are orthogonal to biology. To apply the strain-promoted alkyne-azide cycloaddition (SPAAC) to drive membrane fusion, oxo-dibenzocyclooctyne (ODIBO)-lipid 1 was designed, synthesized, and studied alongside azadibenzocyclooctyne (ADIBO)-lipids 2-4 to assess fusion with liposomes containing azido-lipid 5. Lipids 1-2 were first shown to be effective for liposome derivatization. Next, fusion was evaluated using liposomes containing 1 and varying ratios of PC and PE via a FRET dilution fusion assay, and a 1:1 PC-to-PE ratio yielded the greatest signal change attributed to fusion. Finally, lipids 1-4 were compared, and 1 yielded the greatest triggering of fusion, while 2-4 yielded varying efficacies depending on the structural features of each lipid. Fusion was further validated through STEM studies showing larger multilamellar assemblies after liposome mixing, and FRET assay results supporting the mixing of liposome aqueous contents. This work provides a platform for triggered fusion toward drug delivery applications and an understanding of the effects of lipid structure and membrane composition on fusion.

SUBMITTER: Whitehead SA 

PROVIDER: S-EPMC5990007 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Artificial Membrane Fusion Triggered by Strain-Promoted Alkyne-Azide Cycloaddition.

Whitehead Stuart A SA   McNitt Christopher D CD   Mattern-Schain Samuel I SI   Carr Adam J AJ   Alam Shahrina S   Popik Vladimir V VV   Best Michael D MD  

Bioconjugate chemistry 20170314 4


Artificial systems for controlled membrane fusion applicable for drug delivery would ideally use triggers that are orthogonal to biology. To apply the strain-promoted alkyne-azide cycloaddition (SPAAC) to drive membrane fusion, oxo-dibenzocyclooctyne (ODIBO)-lipid 1 was designed, synthesized, and studied alongside azadibenzocyclooctyne (ADIBO)-lipids 2-4 to assess fusion with liposomes containing azido-lipid 5. Lipids 1-2 were first shown to be effective for liposome derivatization. Next, fusion  ...[more]

Similar Datasets

| S-EPMC3996923 | biostudies-literature
| S-EPMC5967854 | biostudies-literature
| S-EPMC8163418 | biostudies-literature
| S-EPMC3069858 | biostudies-literature
| S-EPMC3474869 | biostudies-literature
| S-EPMC5991799 | biostudies-literature
| S-EPMC5999037 | biostudies-literature
| S-EPMC8778659 | biostudies-literature
| S-EPMC2871956 | biostudies-literature
| S-EPMC6391941 | biostudies-literature